Tilray Medical Applauds German Bundestag And Landmark Passage Of Medical Cannabis Act In Germany
Tilray Brands (NASDAQ:TLRY) announced that its medical cannabis division, Tilray Medical “enthusiastically welcomes” the opening of the German medical cannabis market and the positive paradigm shift in German drug policy.
Friday’s landmark passage of the German Medical Cannabis Act represents a significant step forward and puts public health in the spotlight while providing patients with easier access to high-quality cannabis medicines produced in Germany, noted Tilray in a press release.
“The decision to open up the previously limited German medical cannabis market is an important step that will allow patients and physicians to explore effective treatment options tailored to individual needs,” said Denise Faltischek, Tilray Medical’s chief strategy officer …